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Interactions amongst different amyloid proteins have been proposed as a probable
mechanism of aggregation and thus an important risk factor for the onset as
well as progression of various neurodegenerative disorders including Alzheimer’s,
Parkinson’s, Huntington’s, and Amyotrophic Lateral Sclerosis. Evidences suggest that
transthyretin (TTR), a plasma protein associated with transthyretin amyloidosis or familial
polyneuropathy (FAP) interacts with heterologous amyloid proteins including amyloid
beta and islet amyloid polypeptide. In addition, recent clinical studies have revealed the
presence of systemic polyneuropathy associated with FAP mutations in patients with
spinocerebral ataxia, amyotrophic lateral sclerosis, and new familial systematic prion
disease. Hence, it is important to investigate the interactions amongst different amyloid
proteins to gain better insight into the pathology of amyloid disorders. Yeast has been
an excellent model system to study interaction/ cross-seeding between heterologous
amyloid proteins, more because of presence of endogenous yeast prions. Here, we
examined interactions of non-glutamine (non-Q)-rich transthyretin, with glutamine (Q)-rich
yeast prion protein Sup35. We established aggregation of an engineered double
(F87M/L110M) mutant M-TTR-GFP in yeast. This mutant is monomeric and readily
formed aggregates compared to WT-TTR-GFP in yeast at acidic pH. Interestingly,
aggregation of M-TTR-GFP was significantly enhanced in presence of [PSI+], an
endogenous prion form of Sup35. Different variants of [PSI+] seeded M-TTR-GFP
with different efficiencies and curing of [PSI+] (losing the prion form) in these strains
reduced aggregation. Moreover, overexpression of prion domain of Sup35 fused to
RFP (NM-RFP) also increased M-TTR-GFP aggregation. M-TTR-GFP and NM-RFP
aggregates co-localized in perivacuolar and juxtranuclear region. Sup35 protein was even
immunocaptured in M-TTR-GFP aggregates. However, M-TTR-GFP overexpression did
not induce Sup35 aggregation. Thus, it appears to be a unidirectional interaction
between these two amyloid proteins. However, no affect on M-TTR-GFP aggregation
was observed due to another yeast prion, [PIN+]. Our findings thus show the molecular
interaction of transthyretin with yeast prion and support that sequence similarity is not
the prime requirement for heterologous amyloid interactions.
Keywords: amyloid aggregation, cross-seeding, transthyretin, Sup35 protein, yeast prion [PSI+]
Verma et al. Transthyretin Interacts With Yeast Prion, [PSI+]
INTRODUCTION
Transthyretin amyloidosis (ATTR) is one of the most common
forms of hereditary systemic amyloidosis caused due to
abnormal accumulation of transthyretin protein (TTR) in various
organs/tissues. More than 100 point mutations in TTR have
been associated with the disease. Even the wild type TTR has an
intrinsic propensity to form aggregates and cause late onset of
the sporadic form of ATTR. TTR is a tetramer in its native state
and the point mutations destabilize the tetramer into monomers
which undergo conformational changes (Hammarström et al.,
2002). These misfolded monomers self-assemble to form a seed
or nuclei during the lag phase. This seed serves as a template
to recruit more misfolded monomers/conformers and catalyze
its own polymerization. Therefore, the formation of nuclei or
seed is considered as the time-limiting step in the process of
fibrillization. The introduction of preformed “seed” can reduce
or eliminate the lag phase and accelerate fibrillization. Evidences
suggest that this “seed” could be homologous or heterologous in
nature (Jarrett and Lansbury, 1993; Morales et al., 2009, 2013).
The evidence for cross seeding of TTR was first suggested by
an in vitro experiment, where addition of IAPP fibrils enhanced
TTR aggregation (Westermark and Westermark, 2008). Further,
several reports showed interaction of TTR with other amyloid
proteins including Aβ (Schwarzman et al., 1994; Choi et al.,
2007; Wati et al., 2009) and α-synuclein (Guerreiro et al., 2012).
Recently, a new familial form of human prion disease defined
as PrP systemic amyloidosis has been reported to show clinical
overlap with familial amyloid polyneuropathy, which is known
to be associated with TTR mutations (Mead et al., 2013; Mead
and Reilly, 2015).
Yeast has served as an excellent model system to investigate
homologous and heterologous seeding amongst amyloid
proteins. Interestingly, yeast has endogenous prions (Wickner,
1994; Wickner et al., 1995; Patino et al., 1996; Liebman and
Derkatch, 1999; Du et al., 2008; Patel et al., 2009), which interact
with heterologous prions and other amyloid proteins, thus
providing the proof of concept of cross-seeding hypothesis.
Endogenous glutamine-rich (Q-rich) yeast prions promote or
inhibit induction of other Q-rich yeast prions (Derkatch et al.,
2001; Schwimmer and Masison, 2002; Bradley and Liebman,
2003; Kryndushkin et al., 2008; Yang et al., 2013; Du and Li, 2014;
Ripaud et al., 2014). In addition, yeast prions have been shown to
promote aggregation of other polyQ proteins such as huntingtin,
a human amyloid protein (Meriin et al., 2002; Derkatch et al.,
2004; Zhao et al., 2012; Kantcheva et al., 2014). Increasing
line of evidence now shows interactions amongst Q-rich and
non-Q-rich amyloid proteins also. Non-Q-rich human insulin,
Ig light chain and yeast prion Mod5 promote Q-rich Sup35
aggregation though with varying intensities (Derkatch et al.,
2004; Arslan et al., 2015). Even Q-rich yeast prion [PIN+]
enhanced aggregation of non-Q/N rich fungal prion protein
Het-s (Taneja et al., 2007). Evidences also indicate that some
Abbreviations: TTR, transthyretin; WT-TTR, wild type transthyretin; M-TTR,
monomeric transthyretin; AB, amyloid beta; GFP, green fluorescence protein;
GuHCl, guanidine hydrochloride.
of the interactions between amyloid proteins are reciprocal
(both amyloid proteins can promote aggregation of each other)
whereas some are unidirectional (one amyloid protein promotes
aggregation of the second amyloid protein but not vice-a-versa)
(O’Nuallain et al., 2004; Westermark and Westermark, 2008).
Similar to strains of mammalian prion protein (Safar et al.,
1998; Jones and Surewicz, 2005), yeast prions are known to
exist as biological variants, which exhibit variable phenotype,
aggregation and seeding/ cross-seeding abilities (Derkatch et al.,
1996; Schlumpberger et al., 2001; Uptain et al., 2001). Variants
of yeast prions, [PSI+] and [PIN+], have been well studied.
Distinct variants of [PSI+] have been classified as strong [PSI+]
or weak [PSI+] based on different functional activity and ability
to form aggregates (Derkatch et al., 1996; Zhou et al., 1999).
Furthermore, these prion variants have been shown to interact
differently with other amyloid proteins. Variants of the [PIN+]
prion induce [PSI+] with different efficiencies (Bradley et al.,
2002). These differences amongst the prion variants can probably
be explained by the ability of a protein to misfold into a range of
conformers giving rise to different aggregated forms (Krishnan
and Lindquist, 2005; Tanaka et al., 2006; Toyama et al., 2007).
Accumulating evidences suggest interactions amongst
different heterologous amyloid proteins to be one of the risk
factors in the pathogenesis of amyloid disorders. Hence, it
is important to investigate how presence of one amyloid
disease might influence the onset and progression of another.
Examining the molecular interactions between heterologous
amyloid proteins will help to gain better insight into disease
pathology. In this study, we created transthyretin aggregation
model in yeast and examined the interaction of TTR with
endogenous yeast prion proteins. We observed that Q-rich
yeast prion protein Sup35 directly interacts and enhances
aggregation of non-Q-rich TTR. However, similar to previous
report (Derkatch et al., 2004), overexpression of TTR did not
induce Sup35 aggregation indicating a unidirectional interaction
among them. Our findings suggest that not just sequence
similarity but conformational fold may promote interactions
among heterologous amyloid proteins and hence, support the
cross-seeding hypothesis for the onset of aggregation and disease
progression.
MATERIALS AND METHODS
Yeast Strains, Media, and Plasmids
Yeast strains VL1, a [psi−][PIN+]; VL2, a [psi−][pin−]; VL3,
a weak [PSI+][pin−]; VL4, a strong [PSI+][pin−] in 74-D694
background (ade1-14 ura3-52 leu2-3, 112 trp1-289, his3-200)
were a kind gift from Dr. Susan Liebman. L2723, a SUP35
deletion strain (sup351:LEU2) episomally expressing full length
(N-MRF) Sup35 (pRS313-N-MRF, HIS) in 74-D694 was also a
gift from Dr. Liebman’s lab (Bagriantsev and Liebman, 2006). As
described by them, a control strain was generated by replacing the
pRS313-N-MRF with plasmid pRS316-MRF expressing only the
C-domain of Sup35 (MRF). W303, a wild type (leu2-3,112 trp1-1
can1-100 ura3-1 ade2-1 his3-11,15) yeast strain was also used.
Yeast cells were grown in standard media. Rich media
contained either 1 or 0.25% yeast extract, 2% peptone and 2%
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dextrose. Synthetic minimal media contained all amino acids
except those used for selection and 2% dextrose (SD). For
overexpression constructs dextrose was replaced with raffinose
(2%) and galactose (3%) (SRaf+Gal) in minimal media. To
examine the effect of pH, media pH was adjusted to 4.2 with HCl
and 6.5 with NaOH. Yeast transformations were done by lithium
acetate protocol (Gietz and Woods, 2002).
The plasmid, pRS316-MRF, expressing only the C-domain
of Sup35 and another plasmid pNM-RFP for overexpression
of prion domain (NM) of Sup35 fused to RFP were again a
gift from Dr. Susan Liebman. The wild type TTR-GFP fusion
construct was generated by amplifying the full length human
transthyretin cDNA from pDNR-LIB clone and inserting it
upstream of GFP in a centromeric plasmid, pRS316CG. WT-
TTR-GFP fusion fragment was then amplified and cloned
at BamHI site in pRS424-GAL1, a 2 micron expression
vector to generate pWT-TTR-GFP. Plasmid pM-TTR-GFP was
obtained by introducing two point mutations simultaneously;
methionine substitution at phenylalanine 87 position (F87M)
and methionine substitution at leucine 110 position (L110M)
in WT-TTR-GFP using QuickChange site-directed mutagenesis
procedure from Stratagene (Cat# 200516). A vector control
(pGFP) was created by digesting pWT-TTR-GFP with SacII
enzyme and subcloning the GFP fragment at SacII site in pRS424-
GAL1 vector. All the clones were verified by restriction digestion
and DNA sequencing.
Quantification of Amyloid Aggregates in
Yeast by Fluorescent Microscopy
Different yeast strains were transformed with either TTR-
GFP overexpression constructs alone or co-transformed with
plasmids expressing N-MRF or MRF. Cells were grown in
synthetic glucose selection media and reinnoculated in inducing
media. (SRaf+Gal) TTR aggregates were analyzed after 72 h
using a Nikon Ti-E inverted fluorescent microscope. For
each transformant, six or more microscopic visual fields were
randomly selected and cells with aggregates and diffused GFP
expression were manually counted. More than 600 cells were
counted per transformant and three independent transformants
were analyzed for each construct.
Determining the Native State of TTR-GFP
in Yeast
Yeast cells overexpressing WT-TTR-GFP or M-TTR-GFP were
harvested after 24 h of incubation in the inducing media and
lysed using 1X lysis buffer (50mM TrisCl, 50mM KCl, 10mM
MgCl2, 5% glycerol). Cell lysates were normalized for total
protein and incubated at 37 and 95◦C in non-denaturing sample
buffer without β-mercaptoethanol and resolved on 12% SDS-
PAGE. The blot was probed using anti-GFP antibody (Cat#
G6795, Sigma).
Centrifugation Assay to Analyze the
Distribution of Overexpressed
WT-TTR-GFP and M-TTR-GFP in Yeast
Cell lysates were normalized for total protein at 100 µg/µl
and 1mg of total protein was centrifuged at 40,000 rpm for
3 h at 4◦C. Supernatant fraction was aspirated and the pellet
fraction was resuspended in the same volume (100 µl) of 1X
lysis buffer as the supernatant. Equal volumes of supernatant
and pellet fractions were loaded. Total protein loaded was one-
tenth of the normalized protein for both the samples. The total,
supernatant and pellet fractions were resolved on 10% SDS-
PAGE, immunoblotted and probed using anti GFP antibody.
Determining the Effect of Overexpression
of WT-TTR-GFP and M-TTR-GFP on Cell
Viability in Yeast
Effect of over-expression of WT-TTR-GFP and M-TTR-GFP was
measured by spotting serial dilutions of exponentially growing
liquid cultures. Yeast cells with WT-TTR-GFP or M-TTR-GFP
were grown in raffinose media till early log phase (0.3–0.4). The
cultures were normalized to 0.2 OD and 5-fold serial dilutions
were prepared (5−1, 5−2, 5−3, and 5−4). 5 µl of each dilution was
spotted on glucose (uninduced media) and galactose (inducing
media) selection plates and incubated at 30◦C for 2–3 days.
Determining the Affect of pH of the Media
on Intracellular pH of the Yeast Cells
Yeast cells were grown in SDmedia maintained at different pH at
30◦C for 24 and 36 h. Cells were harvested, washed and incubated
with 500 nM of Lysotracker Red DND-99 (Cat# L7528) at 30◦C
for 30min in their respective media. Cells were washed and
visualized using confocal laser scanning microscope Leica TCS
SP8. Images were processed using LAS X 3.1.1 software.
Examining the Expression Levels of
WT-TTR-GFP and M-TTR-GFP
Protein levels of the WT-TTR-GFP and M-TTR-GFP in yeast
were determined by lysing the cells, normalizing the total protein
and immunoblotting using anti-GFP antibody under the defined
experimental conditions (different pH, yeast strain variants).
GAPDH was used as the endogenous loading control.
Examining Cellular Localization and
Interaction of TTR Aggregates With Sup35
Aggregates
Yeast cells expressing M-TTR-GFP aggregates were stained
with, 4,6-diamidino-2-phenylindole (DAPI), a nuclear DNA-
binding dye and FM4-64, an endocytic vesicle and vacuolar
membrane dye. For nuclear staining, cells were fixed with 10%
formaldehyde for 2 h, washed with phosphate-buffered saline
(PBS), permeabilized by incubation in 70% ethanol for 30min at
room temperature. Cells were washed again and incubated with
DAPI (1µg/ml) for 10min and visualized. For vacuolar staining,
cells were incubated with 8µM FM4-64 in YPD for 15min at
30◦C. Cells were washed and further incubated for 60min in
fresh YPD and then visualized under fluorescent microscope.
Colocalization of M-TTR-GFP aggregates and Sup35
aggregates were monitored by co-transforming M-TTR-GFP
and prion domain (NM) of Sup35 fused with RFP (NM-
RFP). Colocalization was evaluated visually, quantitatively
and statistically. Cells from independent transformants were
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analyzed under fluorescent microscope (Nikon Ti, 100X with
oil immersion) for aggregates after 72 h under FITC (GFP) and
TRITC (RFP) channels and images were captured separately for
both the channels. Colocalization was analyzed by merging the
images from two channels using NIS-Elements AR 3.2. Cells
with M-TTR-GFP, NM-RFP or both M-TTR-GFP/NM-RFP
aggregates were manually counted to calculate the percentage of
cells showing colocalized aggregates. The degree of colocalization
between the fluorophore conjugated proteins (M-TTR-GFP and
NM-RFP) was quantified by calculating Pearson’s correlation
coefficient using Coloc2 Fiji pluggin of the ImageJ software.
Examine the Effect of TTR Aggregation on
Sup35 by Red/White Color Plate Assay
To determine the effect of M-TTR on aggregation of Sup35,
M-TTR-GFP construct was transformed in 1 sup35 strain
maintained by either N-MRF (expressing full length Sup35 where
N is the prion domain) or MRF (expressing only functional
domain of Sup35). This strain also has an ade1 mutation which
encodes for a premature stop codon. Cells were grown in
SRaf+Gal selection media, normalized at 0.2 OD and 5 µl of
each culture was spotted on 1/4 YPD agar plates and adenine
deficient (-Ade) plates. Growth on -Ade plates was monitored
after incubating at 30◦C for 3 days. The color saturation on YPD
medium was observed after incubation at 30◦C for 2 days and
then at 4◦C for 3 days. If Sup35 protein which is a translation
termination factor is functional, it terminates the translation
of ADE1 gene at the premature stop codon which results in
accumulation of a red pigment giving red coloration to yeast
cells on rich media and reduced or no growth on media lacking
adenine. However, if Sup35 is in the aggregated form and its
function is impaired, it leads to read-through of the premature
stop codon and synthesis of full length Ade1 protein. There is
no accumulation of red pigment, yeast cells appear white on rich
media and grow on media lacking adenine.
Curing of Yeast Prions by Subculturing
Yeast Cells on Guanidine Hydrochloride
Media
Transformants expressing M-TTR-GFP in different variants of
yeast prions: [psi−], weak [PSI+], strong [PSI+], [pin−], and
[PIN+] were cured of the prions by subculturing the cells 4 to
5 times on YPD plate containing 5mM guanidine hydrochloride
(GuHCl) at 30◦C till the colonies turned red from pink or white
on YPD plates.
Examining the Interaction of M-TTR-GFP
and Endogenous Sup35 Aggregates in
Yeast by Co-immunoprecipitation
The imunoprecipitation was performed according to the Catch
and Release kit protocol (Cat#17-500). Briefly, the protein
was isolated from weak [PSI+] cells over-expressing either
M-TTR-GFP fusion protein or GFP alone by standard glass
bead method using 1X lysis buffer (100mM Tris Cl, 100mM
KCl, 20mM MgCl2 and 10% glycerol) and total protein
was estimated by BCA pierce kit (Cat# 23225). 1mg of
total lysate was incubated with 10 µl of anti-GFP antibodies
(Cat# G1544) on column containing resin for overnight at
4◦C in continuous rotation. Following incubation, the resin
in the column was washed twice with 1X wash buffer to
remove non-specifically bound proteins. Immunoprecipitated
protein complexes were eluted with hot (95◦C) 1X denaturing
elution buffer, resolved by 10% SDS-polyacrylamide gels, and
analyzed by immunoblotting using antibodies against the
Sup35 (BE4, a polyclonal antibody, was a kind gift from
Susan Liebman) and GFP (monoclonal antibody, Sigma Cat#
6795).
Statistical Analysis
Statistical analysis was performed using SPSS software for
Windows, version 17.0 (SPSS, Chicago, Illinois). Data was
checked for normality and two-tailed t-test was applied to
determine the statistical significance and p-value less than 0.05
was considered to be significant.
RESULTS
An Engineered Double Mutant TTR
(M-TTR-GFP) Is Monomeric in Yeast and
Forms Enhanced Aggregation Compared
to Wild Type TTR (WT-TTR-GFP)
To investigate TTR aggregation, wild type TTR was fused to
GFP (WT-TTR-GFP) and overexpressed in yeast as described in
Materials and Methods section. On overexpression of WT-TTR-
GFP, most of the cells showed diffused fluorescence and only
5–7% of cells showed dot-like visible aggregates (Figures 1A,B).
Since destabilization of TTR tetramer to monomer is important
for aggregation, the native state of WT-TTR-GFP was analyzed.
WT-TTR-GFP appeared to migrate as a higher molecular weight
species at ∼120 KDa (Figure 1C, lane 3). It is possible that
in yeast WT-TTR-GFP exists as either trimer or tetramer
that dissociates into trimer under our experimental conditions
(2% SDS without β-mercaptoethanol at 37◦C). These higher
molecular weight species dissociated into monomer when
incubated at 95◦C (Figure 1C, lane 5). Another possibility is that
these higher molecular weight species occur due to interaction
of TTR with other cellular components. However, we reasoned
it to be a trimer because trimer species have been shown to
populate in the serum (Cubedo et al., 2012). Moreover, WT-TTR
tetramers are formed by sequential addition of monomers; and
trimer intermediates have been observed in vitro (Wiseman et al.,
2005).
We then introduced two previously (Jiang et al., 2001)
defined point mutations, F87M at the monomer-monomer
and L110M at the dimer-dimer interface of WT-TTR, which
destabilizes the TTR tetramer. As expected, this engineered
double mutant, M-TTR-GFP, existed as monomer in yeast
(Figure 1C, lane 2) and did not migrate at higher molecular
weight. On overexpression of M-TTR-GFP, no aggregation of
M-TTR-GFP was observed at 24 h and very minute dot-like
aggregates start appearing between 36 and 48 h (Figure S1).
The aggregates became clearly visible at ∼72 h of incubation
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FIGURE 1 | Aggregation and native state of WT-TTR and M-TTR in yeast. (A) The microscopic images of TTR aggregation state in yeast cells overexpressing
WT-TTR-GFP and M-TTR-GFP after incubation for 72 h at 30◦C. (B) The aggregate formation due to overexpression of WT-TTR-GFP and M-TTR-GFP was quantified
in 74D-694 and W303 strains by calculating percentage of cells with aggregates. Three independent transformants and more than 600 cells were analyzed for each
construct. Error bars represent standard errors of the mean of the three transformants. The significant difference in aggregation between WT-TTR-GFP and
M-TTR-GFP was analyzed by using two-tailed t-test (*depicts p-value < 0.05). The inset on top shows the equal protein levels of WT-TTR-GFP and M-TTR-GFP as
determined by immunoblotting with anti-GFP antibody. (C) Western blot showing the native state of WT-TTR-GFP and M-TTR-GFP in yeast. Cells expressing the two
GFP fusion constructs were harvested after 24 h, lysed and the lysates were incubated under non-denaturing (37◦C and without β-ME) and denaturing (95◦C with
β-ME) conditions. Samples were resolved on 10% SDS-PAGE and immunoblotted using anti-GFP antibody. (D) Centrifugation assay showing the distribution of
WT-TTR-GFP and M-TTR-GFP in supernatant (Sup) and pellet fraction. Cells expressing the WT-TTR-GFP and M-TTR-GFP were harvested after 72 h and protein was
isolated. Total protein was normalized before subjecting to centrifugation and equal volumes of all the fractions were loaded. The fractions were resolved on 10% SDS
and probed using anti-GFP antibody. One tenth of total protein has been used as a loading control. (E) Cellular localization of M-TTR-GFP aggregates was analyzed
by staining cells overexpressing M-TTR-GFP aggregates with FM4-64 (vacuolar) and DAPI (nuclear) dye. The images of same cells were captured under FITC and
DAPI filters. The images were merged to analyze the localization of M-TTR-GFP aggregates. The white arrows in the merged panel shows the aggregates localized
near the vacuole (FM4-64) and nucleus (DAPI).
in inducing media under fluorescent microscope. A significant
(p < 0.05) and approximately 5-fold increase in percentage of
cells with dot-like visible aggregates compared to WT-TTR-
GFP in two different (74D-694 and W303) yeast backgrounds
(Figures 1A,B) was observed at 72 h. It is important to point out
that more WT-TTR-GFP protein was present in the insoluble
pellet fraction compared to supernatant suggesting presence of
non-visible higher molecular weight species on overexpression
of WT-TTR-GFP. These higher molecular weight species are the
biochemical aggregates which are not visible using microscopic
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techniques andmay include aggregation intermediates. However,
M-TTR-GFP fractionated more than 2-fold in the pellet as
compared to the WT-TTR-GFP (Figure 1D). It was further
ensured that the increase in aggregation was not due to any
difference in the expression levels of WT-TTR-GFP and M-TTR-
GFP (Figure 1B, inset). The effect of aggregates on viability of
yeast was monitored by dilution spotting and 7-AAD staining.
No effect on growth or viability of yeast cells was observed
on either episomal or stable overexpression of WT-TTR-GFP
or M-TTR-GFP (data not shown). Thus, TTR-GFP aggregates
appeared to be non-toxic in yeast.
Further, to visualize the cellular localization of M-TTR-
GFP aggregates, cells overexpressing M-TTR-GFP were stained
with FM4-64 (vacuolar staining dye) and DAPI (nucleolar
staining dye). Similar to several other amyloid proteins, bigger
M-TTR-GFP aggregates were observed at periphery of vacuole
and smaller aggregates near the nucleus (Braun et al., 2010)
(Figure 1E).
The pH has been previously shown to be a factor that triggers
tetramer dissociation, partial unfolding and aggregation of TTR
in vitro (Jiang et al., 2001; Lim et al., 2013; Xue et al., 2014). It
has been earlier contested and demonstrated that intracellular
pH of yeast is altered by the external pH (Slavík, 1983; Thevelein
et al., 1987). We also analyzed the affect of pH of media on
the intracellular pH of yeast cells using Lysotracker Red probe
which is an acidotropic probe and commonly used to stain acidic
organelles. At external pH 7.4, vacuoles, the acidic compartment
of yeast, were stained in all the cells and no cytoplasmic staining
was observed. At pH 6.5, vacuoles were stained in more than
80% of the cells and cytoplasmic staining was observed in
approximately 20% of the cells. Interestingly, at pH 4.2, more
than 90% of the cells showed cytoplasmic staining suggesting
the acidic nature of the cell interior (Figure 2C). There was no
difference in Lysotracker staining after culturing for 24 or 36 h in
media with different pH.
To monitor whether pH of the media has any effect on
TTR aggregation in yeast, cells expressing either WT-TTR-
GFP or M-TTR-GFP constructs were grown in inducing media
with different pH. The percentage of cells exhibiting M-
TTR-GFP aggregates was significantly reduced by 4-fold at
higher pH compared to acidic pH (Figure 2A). Even, the WT-
TTR-GFP aggregates were completely abolished at pH 6.5.
It was also ascertained that the difference in aggregation at
two different pHs was not due to different expression levels
(Figure 2A, inset) or cell death as monitored by dilution
spotting (Figure 2B) and 7-AAD staining (data not shown).
Thus, WT-TTR-GFP or M-TTR-GFP aggregation in yeast
is susceptible to acidic pH and recapitulates the in vitro
scenario.
[PSI+], an Endogenous Prion Form of
Sup35 Enhances Visible M-TTR-GFP
Aggregates
Endogenous yeast prions have been suggested to interact
with other amyloid proteins. [PSI+] is a phenotypic trait of
endogenous prion form of Sup35p and exists as different variants
in yeast (Uptain et al., 2001) whereas [psi−] represents the non-
prion form of Sup35p. In order to determine the interaction of
TTR with yeast prion protein Sup35, we examined the effect
of variants of [PSI+] on M-TTR-GFP aggregation. A significant
(p < 0.05) 2-fold increase in cells with visible M-TTR-GFP
aggregates was observed in weak [PSI+] and more than 1.5-folds
in strong [PSI+] as compared to [psi−] strain (Figure 3A, dark
gray bars). Again, the difference in aggregation was not due to
any significant change in expression levels of M-TTR-GFP in the
different strains (Figure 3A, left inset).
To confirm that the enhanced aggregation of TTR is solely
due to presence of [PSI+], endogenous prion was cured from
these transformants by passaging 8–10 times on guanidine
hydrochloride (GuHCl) plates. Curing of [PSI+] leads to the
elimination of prion and was monitored by change in coloration
from white/pink ([PSI+]) to red as in ([psi−]) strain (Figure 3A
right inset). After curing of the prion, the expression of
M-TTR-GFP was re-induced in these [psi−] cells. Interestingly,
M-TTR-GFP aggregation was remarkably reduced on losing the
prion form of Sup35. (Figure 3A, light gray bars). This data
indicates that yeast prion, [PSI+] is able to promote M-TTR-GFP
aggregation.
Additionally, we overexpressed M-TTR-GFP in another
[PSI+] sup351 ade1-14 strain maintained by full length Sup35
expressed on a plasmid (N-MRF). The control non-prion form
of this strain was maintained by expressing only the functional
domain (MRF) but lacking the prion (N) domain of Sup35.
Even in this strain background, a significant (p < 0.05) 2-
fold increase in cells with visible aggregates of M-TTR-GFP
was observed in the presence of aggregated N-MRF [PSI+] as
compared to soluble MRF strain (Figure 3B, upper panel). This
again supported the interaction amongst these two heterologous
amyloid proteins lacking any sequence similarity. We further
exploited this experimental set up to examine if overexpression
of M-TTR-GFP cures [PSI+]. On overexpressing GFP alone, N-
MRF [PSI+] strain is white or pink in color on YPD media and
grows on -Ade media whereas cells expressing the functional,
non-aggregated MRF domain of Sup35 are red on YPD and
do not grow on -Ade media (Figure 3B, lower panel). On
overexpression of M-TTR-GFP, however, no change in the color
of the N-MRF expressing cells on rich media or growth on
-Ade media (Figure 3B, lower panel) was observed. Thus, it
appears that M-TTR-GFP is not able to cure the yeast prion,
[PSI+].
To further verify whether these two heterologous amyloid
aggregates are merely sharing the common cellular space or
they exhibit any direct interaction, M-TTR-GFP fusion protein
was overexpressed in a weak [PSI+] strain and M-TTR-GFP
aggregates were pulled down using anti-GFP antibody. Sup35
protein co-immunoprecipated with M-TTR-GFP aggregates but
was not pulled down from the cells overexpressing GFP alone
as the control (Figure 3C). This observation suggests that Sup35
directly interacts with M-TTR aggregates.
In addition to [PSI+], another yeast prion [PIN+] was also
examined for its effect on M-TTR aggregation. [PIN+] is the
prion form of Rnq1 and has been shown to induce [PSI+] andHtt
aggregation in yeast. However, we did not observe any significant
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FIGURE 2 | Effect of pH of the inducing media on TTR aggregation. (A) The effect of pH on TTR aggregation in yeast was assessed by overexpressing cells with
WT-TTR-GFP or M-TTR-GFP in inducing media at pH 4.2 and pH 6.5. The percentage of cells with aggregates was counted manually under the microscope. Three
independent transformants for each construct were analyzed under both conditions. Error bars in each graph represent standard errors of the mean of triplicates. To
assess the significance of difference in aggregation of M-TTR-GFP at pH 4.2 and pH 6.5, two-tailed t-test was performed (*depicts p-value < 0.05). Equal levels of
M-TTR-GFP protein at different pH were determined by immunoblotting with anti-GFP antibody. The lower panel shows a representative microscopic image of yeast
cells with M-TTR-GFP aggregates at pH 4.2 and pH 6.5. (B) The viability of cells overexpressing M-TTR-GFP at pH 4.2 and 6.5 was determined by serial dilution
spotting on inducing media (upper panel). (C) The microscopic images showing staining of acidic regions in the cells grown in media for 24 h with different pH using
Lysotracker Red DND. Images were captured using confocal microscope Leica TCS SP8 and processed using LAS X 3.1.1 software.
difference in the percentage of cells with M-TTR-GFP aggregates
in [PIN+] and [pin−] cells (Figure 3D).
Overexpressed Prion (NM) Domain of
Sup35 Enhances M-TTR-GFP Aggregation
To verify the inducing effect of Sup35 on M-TTR aggregation,
we co-overexpressed M-TTR-GFP and prion (NM) domain of
Sup35 fused to RFP (NM-RFP) in a [psi−] [PIN+] strain. A
2-fold increase in M-TTR-GFP aggregation was observed in the
presence of overexpressed NM-RFP (∼21%) as compared to RFP
(∼10%). On analyzing the cells for aggregates, single, two and
multiple dots were observed for M-TTR-GFP and peripheral
rings, lines and dots for NM-RFP as tabulated inTable 1. In about
8% of the cells, both M-TTR-GFP and NM-RFP aggregates were
present and more than 90% of these cells showed colocalization.
The M-TTR-GFP dots colocalized with dot-, line- (at the
ends) and peripheral ring/mesh-like aggregates of NM-RFP
(Figure 4). The Pearson’s correlation coefficient (R2) ranged from
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FIGURE 3 | Effect of endogenous prion strains on M-TTR aggregation. (A) The effect of endogenous prion, [PSI+], on M-TTR aggregation was analyzed by manually
counting percentage of cells with M-TTR-GFP aggregates (under the microscope) in [psi−] (non-prion) and weak and strong variants of [PSI+], depicted as uncured
strains in the graph. Left inset: Equal levels of M-TTR-GFP protein in different strains were determined by immunobloting using anti-GFP antibody. M-TTR-GFP
aggregation was again determined after curing the [PSI+] prion in these strains by passaging on GuHCL (right inset), depicted as cured in the graph. Error bars
represent standard errors of the mean of three independent transformants. The significant difference in aggregation between [PSI+] variants and [psi−] as well as
between uncured and cured strains was assessed by using two-tailed t-test (*depicts p-value < 0.05). (B) Upper panel: Percentage of cells with M-TTR-GFP
aggregates were analyzed in a [PSI+] sup351 ade1-14 strain maintained by either expression of full length (N-MRF) or the functional domain (MRF) lacking the prion
(N) domain of Sup35. The strain expressing MRF could not propagate [PSI+]. Aggregation counting for all the experiments was done for atleast three independent
transformants for each sample. Error bars represent standard errors of the mean of triplicates. To assess the significant difference in M-TTR-GFP aggregation between
N-MRF and MRF expressing cells, two-tailed t-test was performed (*depicts p-value < 0.05). Lower panel: The effect of M-TTR-GFP in curing [PSI+] prion was
analyzed by co-overexpressing M-TTR-GFP and N-MRF in [PSI+] sup351 ade1-14 and spotting on rich media (YPD) and media lacking adenine (-Ade). Cells were
examined for any change in coloration from white/pink (prion) to red (non-prion) on rich media and growth on -Ade media. M-TTR-GFP co-expressed with MRF
(soluble functional domain of Sup35) and GFP alone co-expressed with MRF as well as N-MRF were used as controls. (C) Direct interaction of heterologous
aggregates was examined by pull down of Sup35 with M-TTR-GFP aggregates. A weak [PSI+] strain overexpressing M-TTR-GFP fusion protein were lysed and
incubated with anti-GFP antibody conjugated beads in a column. Cells overexpressing GFP were used as a control. Total protein of M-TTR-GFP and GFP lysates
were normalized before incubation with the anti-GFP beads. The incubation complexes were washed twice (W1 and W2) and co-precipitated protein was eluted
(IP:GFP) and resolved on 10% SDS-PAGE. Blot was probed with anti-GFP and anti-Sup35 (BE4) antibodies. Input fraction is 100 µg of the total protein lysates.
(D) The effect of endogenous yeast prion [PIN+] on M-TTR aggregation was also analyzed by counting the percentage of cells with M-TTR-GFP aggregates in [pin−]
(non-prion) and [PIN+] (prion) form of Rnq1. Aggregation counting was done for three independent transformants for each. Error bars represent standard errors of the
mean of triplicates. The significance of difference in M-TTR-GFP aggregation between [PIN+] and [pin−] samples was analyzed by using two-tailed t-test (*depicts
p-value < 0.05).
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TABLE 1 | Enumeration of colocalization of M-TTR-GFP and NM-RFP aggregates.
% Cells with visible aggregates % Cells with both
M-TTR-GFP and
NM-RFP aggregates
% Cells with
co-localization
M-TTR-GFP aggregates
10.2% single dot
4.5% two dots
6.5% multiple dots
21.2 8.2% 94% of the cells
with both the
aggregates
NM-RFP aggregates
3% peripheral rings
0.7% lines
7.2% dots
10.9
Total number of cells analyzed for co-localization (n) = 610.
0.5 (for rings and lines) to 0.95 (for dots) and suggested a
positive correlation of colocalization. No correlation was found
between M-TTR-GFP and cytoplasmic expression of RFP alone
(Figure 4). This co-localization again supports the probability
of interaction between the two amyloid proteins. However, we
again did not notice any significant increase in aggregation
of NM-RFP (data not shown) due to the overexpression of
M-TTR-GFP compared to GFP. This finding is consistent with
the earlier report where addition of wild type TTR fibrils did
not accelerate aggregation of Sup35-NM-YFP (Derkatch et al.,
2004). Thus, the interaction of M-TTR and Sup35-NM appears
to be unidirectional where overexpression of NM-RFP enhances
M-TTR-GFP aggregation but not vice-a versa.
DISCUSSION
Tetramer dissociation of native TTR to monomers has been
demonstrated to be the rate-limiting step for aggregation. In our
study, wild type TTR fused to GFP exists majorly as trimer or
tetramer in yeast and did not readily form visible aggregates,
which is consistent with a previous observation by Gomes et al.
(2012). Further, in vitro experiments have established that partial
denaturation of transthyretin under acidic conditions cause
structural changes, yielding a conformational intermediate that
can self-assemble to form aggregates (McCutchen et al., 1993; Lai
et al., 1996; Jiang et al., 2001; Lim et al., 2013). Here, we observed
that an engineered monomeric variant of transthyretin (M-TTR)
readily forms aggregates in yeast when cultured in acidic media.
Interestingly, these aggregates diminished significantly at near
physiological pH of the media. It is noteworthy that external pH
has been shown to have effect on the cytoplasmic pH in yeast
(Slavík, 1982, 1983; Valli et al., 2005). Our data also supports that
when pH of the media is acidic, the cell interior also becomes
acidic. Thus, aggregation of M-TTR in yeast recapitulated the
in vitro aggregation (Jiang et al., 2001). We further exploited M-
TTR aggregation model in yeast to examine the interaction of
TTR with yeast prions.
Co-existence of different amyloid proteins and presence
of overlapping clinico-pathological features can be probably
explained by interaction among heterologous amyloid proteins.
It is evident from past many studies that aggregates of one
protein can accelerate or inhibit the de novo appearance of other
amyloid proteins. Most of the earlier studies suggested sequence
similarity to be the determining factor for interaction amongst
heterologous amyloid proteins (Krebs et al., 2004). However,
over the years, several evidences indicate that efficacy of cross-
seeding does not correlate linearly with the sequence similarities.
Mutant Aβ amyloid protein that differs at one amino acid is not
able to seed aggregation of wild type Aβ40 (O’Nuallain et al.,
2004). Interactions among Q-rich and non-Q-rich yeast or fungal
prion proteins [(Sup35 and Mod5) and (Rnq1 and Het-s)] have
also been demonstrated (Taneja et al., 2007; Arslan et al., 2015).
Clinically, oligomerization of α-synuclein that is associated with
Parkinson’s disease has been observed in amyloid plaques in
Alzheimer’s (Hamilton, 2000), Huntington’s (Charles et al., 2000),
and ATTR (Guerreiro et al., 2012). In this study, we investigated
the interaction between human TTR, a non-Q-rich amyloid
protein and yeast prion protein Sup35 in the yeast model. Despite
no sequence similarity, [PSI+], the endogenous prion form
of Sup35 significantly enhanced aggregation of the engineered
monomeric TTR-GFP. Further, variants of [PSI+] have been
suggested to have different structural organizations and seed
amyloid proteins with varying degrees. We also observed
that different variants of [PSI+] seed M-TTR with different
efficiencies. Loss of [PSI+] variants reduced the aggregation of
M-TTR-GFP and thereby showed that enhanced aggregation was
infact due to presence of heterologous seeds of [PSI+]. Increase in
aggregation ofM-TTR-GFP on overexpression of the prion (NM)
domain of Sup35 further suggested the interaction between these
two amyloid proteins. Our data also showed direct interaction
between them as Sup35 was immunocaptured with M-TTR-GFP.
Even the aggregation of WT-TTR-GFP, which showed very low
aggregation, was enhanced in the presence of [PSI+] (data not
shown).
Similar to Sup35 aggregates, M-TTR-GFP aggregates were
also observed in the perivacuolar or juxtranuclear region in the
cell. It can be debated that existing in the same cellular niche
might be increasing the probability of interaction between these
two heterologous amyloid proteins. However, another Q-rich
yeast prion [PIN+], which is known to seed [PSI+] (Derkatch
et al., 2001) and other heterologous amyloid proteins (Meriin
et al., 2002; Derkatch et al., 2004; Taneja et al., 2007), despite
being localized in the same spatial compartments in the cell,
did not cause any significant effect on M-TTR-GFP aggregation.
This brings to the possibility that resemblance of structural fold
between the heterologous seed and misfolded soluble monomer
of the protein to be seeded may influence the interaction and
determine the seeding efficiency. Recent evidences suggest vast
structural diversity among amyloid proteins and even the same
polypeptide can adopt different conformation that give rise
to different variants or strains as observed for prions. Hence,
further structural insight may help in addressing the interaction
between heterologous amyloid proteins and its role in genesis and
progression of various amyloid disorders.
Additionally, our study highlights non-reciprocity in
heterologous seeding. We did not observe any effect of
M-TTR-GFP on Sup35 aggregation as previously shown by
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FIGURE 4 | Colocalization of M-TTR-GFP and Sup35 aggregates. The microscopic images showing colocalization of M-TTR-GFP dots and Sup35 dots-, lines-,
ring/mesh- like aggregates on co-overexpression of M-TTR-GFP and NM domain of Sup35 fused to RFP (NM-RFP) in yeast cells. Images were captured under FITC
(GFP) and TRITC (RFP) channels and merged using NIS-Elements AR3.2 software. Pearson’s correlation coefficient was determined using Coloc2.
Derkatch et al. (2004). They observed occasional colocalization
of Sup35 (NM-YFP) with WT-TTR aggregates but WT-TTR
aggregates did not promote the [PSI+] induction. They stated
that colocalization in the same cellular niche does not necessarily
suggest interaction amongst the two amyloid proteins. However,
our data suggests that this colocalization of M-TTR-GFP and
NM-RFP (Sup35) results in unidirectional interaction which
promotes M-TTR-GFP aggregation but not vice-a-versa. This
lack of reciprocity in seeding has been documented for other
amyloid proteins including Aβ and IAPP (O’Nuallain et al.,
2004) and TTR and IAPP (Westermark and Westermark, 2008).
Thus, we believe that the detailed structural determination
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of TTR and Sup35 may reveal an important aspect of cross
seeding efficiencies. Further, targeting M-TTR to a different
cellular compartment might help to establish that colocalization
and direct interaction with Sup35 aggregates enhances M-TTR
aggregation.
Thus, our findings provide evidence for interaction of
transthyretin, a non-Q-rich amyloid protein with a Q-rich
heterologous yeast prion protein that can be further explored for
their relevance in the clinical scenario. Such interactions between
heterologous amyloid proteins may explain how occurrence of
one amyloid disorder could induce the development of another
amyloid disorder. While our finding that Sup35 directly interacts
with M-TTR aligns with the cross-seeding model, however the
alternate possibility of indirect sequestration of cellular factors
could not be ruled out. Since cellular pathways controlling
aggregate formation appear to be conserved from yeast to
mammals, therefore evaluating titration of other cellular factors
during heterologous interaction might provide new approach for
amyloid disease intervention.
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